November 14, 2025 a 05:00 pm
SRE: Analysts Ratings - Sempra
Sempra's stock demonstrates a stable outlook with a consistent mix of analyst recommendations over recent months. The predominance of 'Buy' and 'Hold' ratings indicates moderate optimism from the market, while the absence of 'Sell' ratings reflects confidence in the company's operational stability and market position.
Historical Stock Grades
| Recommendation | Number | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 8 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Analyst sentiment over recent months shows a stable to slightly optimistic outlook. While 'Strong Buy' ratings have decreased since early 2025, 'Buy' ratings have remained consistent. 'Hold' ratings have slightly increased since mid-year, suggesting a cautious stance among analysts.
- The total number of ratings has seen a gradual increase as more analysts cover Sempra.
- 'Strong Buy' ratings saw a decline, particularly from March 2025 onwards.
- 'Hold' ratings have shown some fluctuation but remain a significant component of overall recommendations.
Percentage Trends
Looking at percentage distribution, there's a notable stability in 'Buy' and 'Hold' categories over recent months. However, a shift from 'Strong Buy' to 'Buy' and 'Hold' highlights a measured optimism. This consistent analyst confidence can be seen as a positive long-term indicator.
- Early 2025 saw 'Strong Buy' ratings at about 20%, decreasing to approximately 10% by November.
- 'Buy' ratings have consistently comprised nearly half of all recommendations.
- There's been a consistent absence of 'Sell' and 'Strong Sell' ratings.
- The most significant shifts were seen between 'Strong Buy' and 'Hold'.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-06 | Overweight | Overweight | Barclays |
| 2025-11-06 | Neutral | Neutral | UBS |
| 2025-10-22 | Hold | Hold | Jefferies |
| 2025-10-22 | Outperform | Outperform | BMO Capital |
| 2025-10-20 | Overweight | Equal Weight | Barclays |
Analyst Recommendations with Change of Opinion
Recent months have shown a tendency towards maintaining positions rather than significant upgrades or downgrades. However, occasional shifts such as Barclays' upgrade to 'Overweight' suggest nuanced confidence in Sempra's prospects.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-20 | Overweight | Equal Weight | Barclays |
| 2025-03-03 | Hold | Buy | Jefferies |
| 2025-02-27 | Equal Weight | Overweight | Barclays |
| 2025-02-26 | Neutral | Buy | UBS |
| 2025-02-26 | Neutral | Buy | Goldman Sachs |
Interpretation
The data suggests a market sentiment that is cautiously optimistic regarding Sempra's future. The reduction in 'Strong Buy' ratings indicates a shift towards a more reserved outlook, though existing 'Buy' ratings signify sustained confidence in the company's potential. While some individual analysts have shifted their recommendations, overall sentiment remains stable, reflecting a balanced view of potential risks and opportunities.
Conclusion
In summary, Sempra's stock continues to receive strong support from analysts, with a majority recommending 'Buy' or 'Hold'. Despite some fluctuations in sentiment, the overall perspective remains positive. Analysts appear to be weighing potential market uncertainties with Sempra's consistent performance, inferring moderate confidence in the company's future prospects. As a whole, the data underscores a stability in analyst opinion, suggesting a resilient outlook amidst market fluctuations.